LNSR
LENSAR, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$7.07
−0.28%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $14.3M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- $0.10
- EPS estimate
- -$0.17
- Revenue actual
- $13.7M
- Revenue estimate
- $14.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +153.3%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.17 | $0.10 | Beat 160.61% | $13.7M |
| May 8, 2026 | $0.18 | $1.56 | Beat 743.24% | $12.6M |
| Mar 31, 2026 | -$0.07 | -$0.12 | Miss -80.72% | $16.0M |
| Nov 6, 2025 | -$0.10 | -$0.31 | Miss -210.00% | $14.3M |
| Aug 7, 2025 | -$0.08 | -$0.15 | Miss -87.50% | $13.9M |
| May 8, 2025 | -$0.15 | -$2.32 | Miss -1446.67% | $14.2M |
| Feb 27, 2025 | -$0.18 | -$1.61 | Miss -794.44% | $16.7M |
| Nov 7, 2024 | -$0.29 | -$0.13 | Beat 55.17% | $13.5M |
| May 9, 2024 | -$0.28 | -$0.19 | Beat 32.14% | $10.6M |
| Mar 4, 2024 | -$0.22 | -$0.35 | Miss -59.09% | $12.1M |
| Nov 9, 2023 | -$0.34 | -$0.23 | Beat 32.35% | $9.8M |
| May 15, 2023 | -$0.27 | -$0.40 | Miss -48.15% | $8.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026